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Synergistic Pathogenic Effects of Combined Mouse
Monoclonal Anti-Desmoglein 3 IgG Antibodies
on Pemphigus Vulgaris Blister Formation
Hiroshi Kawasaki1, Kazuyuki Tsunoda1,2, Tsuyoshi Hata1,3, Ken Ishii1, Taketo Yamada4
and Masayuki Amagai1
Pemphigus vulgaris (PV) is an autoimmune blistering disease caused by anti-desmoglein 3 (Dsg3) IgG
antibodies. Previously, we generated an active mouse model for PV by adoptive transfer of splenocytes
from immunized or naive Dsg3/ mice. In this study, we isolated 10 anti-Dsg3 IgG mAbs (NAK-series) from PV
model mice generated by transfer of naive Dsg3/ splenocytes. We characterized their epitopes using
domain-swapped and point-mutated Dsg1/Dsg3 molecules and examined their pathogenic activities in blister
formation in three different assays. In a passive transfer model using neonatal mice, eight of 10 NAK mAbs
showed pathogenic activity when injected together with half the minimum pathogenic dose of anti-Dsg1 IgG
autoantibodies from pemphigus foliaceus (PF) patients. None of the mAbs could induce the PV phenotype
when individual hybridoma clones were inoculated by peritoneal injection into adult Rag2/ mice. NAK mAbs
displayed a range of potency in an in vitro dissociation assay using primary cultured mouse keratinocytes.
Interestingly, when multiple hybridoma clones recognizing different epitopes were inoculated in combination,
recipient mice developed the PV phenotype. In vitro dissociation assays confirmed that combined NAK mAbs
had synergistic pathogenic effects. These findings indicate that although an individual anti-Dsg3 IgG is not
sufficient to cause blistering in adult mice, several together can induce the PV phenotype. These mAbs will
provide a valuable tool to investigate the molecular mechanisms of blister formation, mimicking the effects of
the polyclonal IgG antibodies found in patients.
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INTRODUCTION
Pemphigus vulgaris (PV) is a fatal autoimmune blistering
disease of the skin and mucous membranes (Amagai, 2003),
which is characterized clinically by flaccid blisters and
erosions, and histopathologically by the loss of cell–cell
adhesion between basal and suprabasal keratinocytes,
resulting in suprabasal acantholysis. The target antigen of
PV is desmoglein 3 (Dsg3), a desmosomal transmembrane
glycoprotein that belongs to the cadherin gene superfamily of
Ca2þ -dependent cell–cell adhesion molecules (Amagai et al.,
1991; Amagai, 1996). Compelling evidence indicates that
IgG autoantibodies against Dsg3 in PV play a primary
pathogenic role in blister formation (Anhalt et al., 1982;
Amagai et al., 1992, 1998; Mahoney et al., 1999).
Previously, we developed a mouse model for PV using
Dsg3/ mice, which should not acquire immunological
tolerance to Dsg3 (Amagai et al., 2000b). After immunization
of Dsg3/ mice with recombinant extracellular domains of
mouse Dsg3, we adoptively transferred splenocytes from the
immunized mice into Rag2/ recipient mice that express
Dsg3. The transferred Dsg3/ lymphocytes stably produced
anti-Dsg3 IgG and the recipient mice developed a PV
phenotype, including oral erosions with histological supra-
basilar acantholysis and telogen hair loss (Koch et al., 1997).
Subsequently, we demonstrated that the adoptive transfer of
naive splenocytes from nonimmunized Dsg3/ mice to
Rag2/ recipients also induced the production of anti-Dsg3
IgG and the PV phenotype (Aoki-Ota et al., 2004). Antibody
production and the appearance of the PV phenotype were
delayed by approximately 2 weeks in mice receiving naive
splenocytes compared to those receiving immunized spleno-
cytes. However, once the PV phenotype developed, there
were no apparent differences in disease severity between
mice induced by the two methods. Interestingly, the anti-
Dsg3 IgG titers were markedly lower in mice that received
naive splenocytes than in mice that received immunized
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splenocytes, suggesting that the antibodies generated in the
former are more potent than those in the latter. Conforma-
tional epitope mapping in model mice revealed that anti-
Dsg3 IgG were predominantly raised against the middle to
C-terminal extracellular domains of mouse Dsg3, where
amino-acid residues are less conserved among desmoglein
isoforms. PV model mice receiving naive splenocytes
produced antibodies against the N-terminal domain of Dsg3
more frequently than mice receiving immunized splenocytes
(Anzai et al., 2004).
We isolated eight anti-Dsg3 IgG mAbs from PV model
mice that received immunized Dsg3/ splenocytes (the AK
series) (Tsunoda et al., 2003). Two of these mAbs were
capable of inducing the loss of cell–cell adhesion in
keratinocytes, as determined in a passive transfer model
using neonatal mice, and one of the two, AK23, was able to
induce the PV phenotype when hybridoma cells were
inoculated into the peritoneal cavities of Rag2/ mice. The
other six mAbs failed to show apparent pathogenic activity, in
spite of their ability to bind the native Dsg3 in vivo.
In the present study, we isolated a further 10 anti-Dsg3 IgG
mAbs from PV model mice that received naive Dsg3/
splenocytes (NAK series). We characterized the pathogenic
activities of these mAbs in three different assays (passive
transfer, ascites formation, and in vitro dissociation), and also
analyzed their conformational epitopes. We found that anti-
Dsg3 mAbs reacting with different parts of the molecule are
synergistic in their pathogenic activity, inducing blister
formation when they are combined.
RESULTS
Production of NAK anti-Dsg3 IgG mAbs from PV model mice
As a source of hybridoma cells, we used splenocytes of PV
model mice generated by adoptive transfer of splenocytes
from naive Dsg3/ mice, which produce more potent
anti-Dsg3 IgG antibodies than mice receiving immunized
Dsg3/ splenocytes (Aoki-Ota et al., 2004). We first
screened the hybridoma cells by ELISA against recombinant
mouse Dsg3; positive clones were further screened by live
staining of mouse keratinocyte PAM212 cells. The second
screening selected mAbs that could bind to the native Dsg3
on keratinocyte cell surfaces in vivo. Ten independent clones
were isolated and designated as NAK mAbs (Table 1).
All of the NAK mAbs had the k isotype light chain. Four
(NAK1, 2, 3, 5) had IgG1 and six (NAK4, 7, 8, 9, 10, 11) had
IgG2a heavy chains (Table 1). Under indirect immunofluor-
escence, all stained keratinocyte cell surfaces in all layers of
the mouse oral mucosa, with stronger intensity toward the
more basal layers (Figure 1, mouse hard palate and see also
Supplementary Figure 1) and in the basal and parabasal
layers of the mouse epidermis (Figure 1, mouse tail skin).
Five mAbs (NAK1, 4, 7, 8, 9) also stained the keratinocyte
cell surfaces of human epidermis, but with different
staining patterns. NAK1 and NAK9 mAbs stained the lower
layers of the human epidermis, NAK4 stained all layers, and
NAK7 and NAK8 stained the middle to upper layers (Figure 1,
human epidermis). With ELISA, all of the mAbs reacted
only with mouse Dsg3 and not with mouse Dsg1. Those
mAbs that showed crossreactivity with human epidermis
Table 1. Characterization of the NAK mAbs
ELISA Pathogenic activity
IIF1 Mouse Human2
Passive Ascites Dissociation
NAK Isotype Mouse Human Dsg3 Dsg1 Dsg3 Dsg1
Live keratinocyte
staining
Ca
dependency3 Epitopes4 transfer5 formation assay6
1 IgG1k + + +  +  + + T25, Y28, Q29 +  14.6
2 IgG1k +  +    + + 195–402 +  25.2
3 IgG1k +  +  +  +  403–565   0.5
4 IgG2ak + + +  + + + + 1–162 +  35.9
5 IgG1k +  +    +  195–402   12.5
7 IgG2ak + + +   + + + 1–162 +  13.4
8 IgG2ak + + +   + + + 1–162 +  25.4
9 IgG2ak + + +  +  + + T25, Y28, Q29, V53 +  45.1
D54, K55, N56
10 IgG2ak +  +    + + 1–162 +  34.9
11 IgG2ak +  +    + + 1–402 +  33.6
IIF, indirect immunofluorescence.
1Indirect immunofluorescence staining. Mouse oral mucosa (hard palate) and human normal skin were used as the substrates.
2ELISA reactivity against human Dsgs was determined with 0.1 mg/ml NAK mAbs.
3The reactivity of NAK mAbs against mouse Dsg3 was determined with or without EDTA treatment. +, indicates the abolition of the reactivity by EDTA.
4The epitopes are indicated by the residue numbers for mouse Dsg3 except those for NAK1 and NAK9 mAbs, whose epitopes are indicated by the residues
for human Dsg3.
5+, indicates gross blister formation when coinjected with PF IgG.
6Dissociation index values are listed when dissociation index obtained by AK23 mAb (Tsunoda et al., 2003) is 100.
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under immunofluorescence also recognized human Dsg3
and/or Dsg1 in different patterns. NAK1, NAK3, and NAK9
reacted with human Dsg3, NAK4 reacted with both
human Dsg3 and Dsg1, and NAK7 and NAK8 reacted with
human Dsg1 (Table 1). The immunofluorescence staining
patterns of NAK mAbs whose IIF was positive on human
epidermis (NAK1, 4, 7, 8, 9) were consistent with the ELISA
results, based on the distribution of Dsg1 and Dsg3 in the
human epidermis (Amagai et al., 1996; Shirakata et al., 1998).
Thus, all NAK mAbs specifically reacted with native
mouse Dsg3 without crossreacting with mouse Dsg1, and
some crossreacted with human Dsg3 and/or Dsg1 in different
patterns.
NAK mAbs recognize different epitopes on Dsg3
To characterize the epitopes of the NAK mAbs, we
determined whether their binding to mouse Dsg3 was
dependent on calcium. Treating a mouse Dsg3-coated ELISA
plate with EDTA did not substantially alter binding of NAK3
and NAK5, but abolished binding of the other mAbs (data not
shown). Therefore, NAK3 and NAK5 mAbs recognized Ca2þ -
independent epitopes, while the other mAbs recognized
Ca2þ -dependent conformational epitopes.
To map the epitopes of the mAbs, we used domain-
swapped mouse Dsg3/Dsg1 recombinant molecules (Anzai
et al., 2004). These molecules are believed to maintain native
conformations, at least in terms of binding anti-Dsg IgG
antibodies (Futei et al., 2000; Sekiguchi et al., 2001). We
used four domain-swapped molecules that contained the
mouse Dsg3 residues 1–162 (mDsg31–162/mDsg1163–512),
1–402 (mDsg31–402/mDsg1403–512), 195–565 (mDsg11–194/
mDsg3195–565), or 403–565 (mDsg11–402/mDsg3403–565).
NAK1, 4, 7, 8, 9, 10 mAbs precipitated residues 1–162 and
1–402, but not residues 195–565 or 403–565 (Figure 2a and
b). Their epitopes appear to reside in residues 1–162, the
N-terminal portion of the extracellular domain of mouse
Dsg3. NAK2 and NAK5 reacted with residues 1–402 and
195–565, but not with residues 1–162 or 403–565 (Figure 2a
and b). Their epitopes appear to be in residues 195–402,
which represent the middle portion of the extracellular
domain. NAK3 precipitated residues 195–565 and 403–565,
but not residues 1–162 or 1–402 (Figure 2a and b). Its epitope
appears to reside in residues 403–565, the C-terminal portion
of the extracellular domain. NAK11 mAb precipitated only
residues 1–402 (Figure 2a and b).
Of these mAbs, NAK1 and NAK9 crossreacted with human
Dsg3 but not with human Dsg1, and recognized the
N-terminal residues 1–162. We used a series of point-mutated
human Dsg3 and Dsg1 molecules, in which Dsg3-specific
residues were replaced by the corresponding Dsg1-specific
residues, or vice versa (Figure 2d; Tsunoda et al., 2003).
NAK1 mAb maintained its reaction with human Dsg3
mutated at T31, K33, I34 (Dsg3-M2), V53-N56 (Dsg3-M3),
E70, S73 (Dsg3-M4), L75, T77 (Dsg3-M5), A83, and Q84
(Dsg3-M6), but lost reactivity when the Dsg3 specific
residues T25, Y28, or Q29 were mutated (Dsg3-M1, M1-2,
M1-2-3) (Figure 2c and d). NAK1 gained recognition of
human Dsg1 modified with Dsg3-specific residues at T25,
Y28, or Q29 (Dsg1-M1-2, M1-2-3) (Figure 2c and d). These
findings indicate that the epitope for NAK1 maps to the T25,
Y28, and Q29 of Dsg3. T25 and Q29 are conserved between
human and mouse Dsg3, but Y28 in the human is replaced by
F28 in the mouse.
Similarly, NAK9 mAb reacted with human Dsg3 mutated
at Dsg3-specific residues T31, K33, I34 (Dsg3-M2), E70, S73
(Dsg3-M4), L75, T77 (Dsg3-M5), A83, and Q84 (Dsg3-M6),
but lost recognition when either T25, Y28, Q29 (M1), or
V53-N56 (Dsg3-M3) were mutated (Figure 2c and d). NAK9
gained recognition of human Dsg1 when mouse residues
T25, Y28, Q29, and V53-N56 were introduced (Dsg1-M1-2-
3), but not when T25, Y28, and Q29 were introduced with
T31, K33, and I34 (Dsg1-M1-2) (Figure 2c and d). These
findings indicate that the epitope of NAK9 mAb maps to the
residues T25, Y28, Q29, V53, D54, K55, and N56. Of these,
Y28 and K55 are not conserved in mouse Dsg3 (F28, P55).
Thus, these NAK mAbs recognize different epitopes on
Dsg3, and six of them recognize the N-terminal 1–162
residues (Table 1).
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Figure 1. Immunostaining of mouse and human tissues with NAK mAbs.
Representative immunostaining is shown (NAK1, NAK4, NAK7, and NAK11).
All of the NAK mAbs stained keratinocyte cell surfaces in all layers of mouse
oral mucosa (mouse hard palate), with stronger intensity toward the lower
layers, and stained the lower layers of mouse epidermis (mouse tail skin),
where Dsg3 is expressed. NAK mAbs reacted with human epidermis in
different patterns (human epidermis); NAK1, NAK4, and NAK7 mAbs stained
the lower portion of, the entire, and the upper portion of human epidermis,
respectively, while NAK11 failed to react with human epidermis. Dashed
lines indicate the basement membrane zone. Bar¼ 50 mm.
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Most NAK mAbs induce blisters in passive transfer to neonatal
mice
To evaluate the pathogenic activities of the mAbs, we first
performed a passive transfer assay using neonatal mice, a
well-established assay for pemphigus (Anhalt et al., 1982;
Amagai et al., 1994). Purified IgG from the culture super-
natant of each hybridoma was injected s.c. into neonatal
mice, and the mice were observed for 18–24 hours postinjec-
tion (Table 2). When individual NAK mAbs were injected,
none of them induced gross blistering; this was expected, as
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mDsg1 1-402/mDsg3 403-565
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Figure 2. Immunoprecipitation of domain-swapped and point-mutated Dsg1/Dsg3 recombinant proteins with NAK mAbs. (a) Immunoprecipitation of
mDsg31–162/mDsg1163–512 (lane 1), mDsg31–402/mDsg1403–512 (lane 2), mDsg11–194/mDsg3195–596 (lane 3), and mDsg11–402/mDsg3403–565 (lane 4) with
various NAK mAbs. (b) The molecular structure of domain-swapped mDsg1/mDsg3 proteins and summary of results for epitope mapping of mAbs.
(c) Immunoprecipitation of various point-mutated hDsg1/hDsg3 proteins with NAK1 (upper panel), NAK9 (middle panel), and anti-E-tag mAb as a positive
control (lower panel). (d) The molecular structure of point-mutated hDsg1/hDsg3 proteins and summary of results for epitope mapping of NAK1 and NAK9
mAbs. The 22 amino-acid residues not conserved between hDsg1 and hDsg3 are indicated. These nonconserved residues were switched between Dsg1
and Dsg3 to generate point-mutated molecules.
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Dsg1 co-expression in the skin of neonatal mice compensates
for the impaired adhesive function of Dsg3 (Figure 3; Amagai,
1999; Mahoney et al., 1999). However, all of the mAbs
except NAK3 induced varying degrees of microscopic
blistering, with histological evidence of suprabasilar acantho-
lysis (Figure 3). We scored the extent of this blistering using
the total area of blisters observed in histology (Table 2).
To overcome the compensation by Dsg1, we used IgG
prepared from pemphigus foliaceus (PF) sera that contained
anti-Dsg1 IgG autoantibodies. We injected one-half of the
minimum dose of PF IgG that had been shown to induce
gross blisters, alone or in combination with NAK mAbs
(Tsunoda et al., 2003). Neonatal mice that were co-injected
with each of the NAK mAbs (except NAK3 and NAK5)
developed extensive gross blisters with suprabasilar acantho-
lysis, while mice injected with the PF IgG alone did not show
any blister formation (Figure 3).
These findings indicate that most of the NAK mAbs are
able to induce the loss of cell–cell adhesion of keratinocytes
in neonatal mice. Only two failed to show pathogenic effects.
None of the individual NAK mAbs induce the PV phenotype in
adult mice
To further evaluate the pathogenic activities of NAK mAbs,
we inoculated individual hybridoma cells intraperitonealy
into Rag2/ immunodeficient mice (6–8 weeks old), and
looked for the appearance of the PV phenotype, which
includes weight loss, patchy hair loss, and mucosal erosions
(Figure 4, Table 3). None of the recipient mice developed this
phenotype, even after obvious ascites fluid formation at day
15. Although all the mice showed in vivo IgG deposition on
keratinocyte cell surfaces of the skin and mucous mem-
branes, no blister formation was apparent in the oral mucosa
at the histological level (Figure 4).
These findings indicate that none of the individual NAK
clones inoculated was potent enough to induce the loss of
cell–cell adhesion of keratinocytes in vivo, during ascites
formation in adult mice.
Combined NAK mAbs induce the PV phenotype in adult mice
To explore the possibility of combined pathogenic effects, we
inoculated NAK hybridoma cells intraperitonealy in various
combinations into Rag2/ mice (Figure 4, Table 3). When
hybridoma cells for NAK1, 2, 4, 7, 8, 9, 10, and 11 were
combined, the recipient mice developed weight loss, patchy
hair loss, and crusted erosions around the snout, at
approximately days 10–15 after the inoculation. These mice
showed suprabasilar acantholysis of the oral mucosa and in
the skin around the snout, together with in vivo IgG
deposition on keratinocyte surfaces. The titers of circulating
anti-Dsg3 IgG in the recipient mice with combined NAK
hybridoma cells were compatible with those with single NAK
hybridoma cells. The development of the PV phenotype was
observed even after mAbs NAK8, NAK4, NAK10, and NAK9
were sequentially removed from the combination (Table 3).
The minimum combination that was sufficient to induce the
PV phenotype in all recipient mice tested was NAK1, NAK2,
NAK7, and NAK11, or NAK2, NAK3, NAK5, and NAK11,
Table 2. Summary of the pathogenic activities of NAK
mAbs in passive transfer assay
NAK alone1 NAK+PF IgG2
Blister formation
NAK n
IgG
deposition
Histologic blister
Scores3 n
Gross
blisters
1 3 + 5.70 3 3
2 3 + 16.31 2 2
3 3 + 0 2 0
4 3 + 38.91 3 1
5 3 + 4.04 2 0
7 3 + 4.82 2 2
8 5 + 6.38 2 2
9 3 + 22.23 2 2
10 3 + 4.77 4 2
11 3 + 9.48 2 2
PF, pemphigus foliaceus.
1NAK mAbs alone were subcutaneously injected into neonatal mice and
the formation of gross or microscopic blisters was noted.
2NAK mAbs were coinjected with 50% of the minimum dose of PF IgG
into neonatal mice and the formation of gross blisters was noted. The
number of mice with the gross blisters was listed.
3The blister score is defined in Materials and Methods.
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Figure 3. Passive transfer assay of NAK mAbs in neonatal mice. All antibodies except NAK3 and NAK5 mAbs (which recognize Ca2þ -independent epitopes)
induced gross PV blisters when co-injected with a dose of PF IgG insufficient to induce blisters on its own. Representative data are shown. Neonatal mice
injected with NAK9, but not with NAK3, developed microscopic blisters with histological suprabasilar acantholysis, without apparent gross blisters. Neonatal
mice co-injected with NAK9, but not NAK3 or PF IgG alone, developed extensive blistering (arrows) with suprabasilar acantholysis. Bar¼50 mm.
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each of which recognize different epitopes on mouse Dsg3
(Table 1). The mice inoculated with hybridoma cells from
these clones developed the full spectrum of PV phenotypic
markers (Figure 4).
When we removed any NAK hybridoma cells from the
above minimum combination, some of the recipient mice
started not to develop the PV phenotype and the other mice
showed the PV phenotype at approximately days 15–20 after
the inoculation (Table 3). The minimum combination that
could induced the PV phenotype at least one of the mice
tested was NAK2 and NAK11 hybridoma cells (Table 3).
These findings indicate that NAK mAbs that are not
sufficient to induce blisters singly are capable of doing so in
adult mice when they are combined.
Pathogenic ranking of NAK mAbs by in vitro dissociation assay
The passive transfer assay with neonatal mice and the ascites
formation assay with Rag2/ adult mice require relatively
large amounts of antibodies, and do not necessarily simulate
pathogenesis in a quantitative fashion. We recently devel-
oped an in vitro dissociation assay using primary cultures of
normal human keratinocytes, as a simple method to quantify
the pathogenic strength of pemphigus autoantibodies (Ishii
et al., 2005). For this study, we modified the assay to evaluate
the pathogenic activity of NAK mAbs against mouse
keratinocytes. To obtain Dsg3-dominated cell–cell adhesion,
we used primary cultured mouse keratinocytes, which
express a low level of Dsg2, in the presence of exfoliative
toxin A, which specifically digests Dsg1 (Amagai et al.,
2000a). After incubation with various NAK mAbs, a sheet of
keratinocytes, released by dispase, were subjected to
mechanical stress by pipetting, and the number of cell sheet
fragments was determined. The number of cell fragments
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Figure 4. Combinations of NAK mAbs induced the PV phenotype when their
hybridoma cells were inoculated intraperitonealy, while the individual mAbs
failed to do so. Mice inoculated with NAK1 hybridoma cells alone did not
develop apparent PV phenotype (day 15 after inoculation) or histological
suprabasilar acantholysis, in spite of apparent ascites formation and in vivo
IgG deposition on keratinocyte cell surfaces of stratified squamous epithelia.
In contrast, when hybridoma cells producing NAK1, NAK2, NAK7, and
NAK11 mAbs were combined, recipient mice developed patchy hair loss as
well as weight loss (day 15). Histology of the oral mucosa showed in vivo IgG
deposition and suprabasilar acantholysis and the skin showed acantholysis
around telogen hair club (inset; arrow heads indicate the location of
acantholysis). Bar¼ 50mm.
Table 3. Summary of the pathogenic activities of NAK
mAbs in ascites formation assays
NAK n
IgG
deposition1
PV
phenotype2
(n (%))
Titers of
circulating
anti-Dsg3 IgG3
1 7 + 0 144.279.3
2 4 + 0 72.971.3
3 10 + 0 230.6738.9
4 5 + 0 ND
5 11 + 0 181.0720.0
7 3 + 0 92.071.0
8 4 + 0 85.371.3
9 8 + 0 111.674.2
10 8 + 0 41.173.3
11 6 + 0 ND
1,2,4,7,8,9,10,11 5 + 5 (100) 114.0714.7
1,2,4,7,9,10,11 3 + 3 (100) 113.670.1
1,2,7,9,11 2 + 2 (100) ND
1,2,7,11 7 + 7 (100) 126.575.9
2,3,5,11 3 + 3 (100) 219.375.9
2,7,11 3 + 2 (67) 77.276.7
1,2,11 4 + 2 (50) 112.172.8
1,2,7 4 + 0 218.375.9
1,7,11 4 + 0 175.5713.0
2,3,5 3 + 0 208.875.9
2,11 3 + 1 (33) 55.775.6
2,7 2 + 0 94.1721.5
7,11 3 + 0 ND
ND, not determinded; PV, pemphigus vulgaris.
Hybridoma cells for individual NAK clones or combinations were
inoculated intraperitonealy into Rag2/ mice.
1IgG deposition on mouse keratinocyte cell surfaces was observed in all
mice injected with NAK mAb hybridomas.
2The development of the PV phenotype, including patchy hair loss and
suprabasilar acantholysis of the oral mucosa, was evaluated. The number
of mice with the PV phenotype was listed.
3Titers of circulating anti-Dsg3 IgG were measured by mDsg3 ELISA at
days 15–20 days after inoculation.
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increased as the concentration of AK23 or various NAK mAbs
increased, indicating that this assay evaluate pathogenic
strength in a quantitative manner (Figure 5a). Dissociation
index values were calculated as a percent of the number of
fragments obtained with a positive control mAb, AK23
(Tsunoda et al., 2003).
Each NAK mAb had a different dissociation index,
indicating that this assay could discriminate differences in
activity among them (Table 1, representative data are shown
in Figure 5b and c). NAK3 and NAK5, which failed to induce
apparent pathogenic activity in the passive transfer model,
gave smaller dissociation indexes than the others (0.5 and
12.5%, respectively), while NAK9 had the highest dissocia-
tion index (45.1%).
When several NAK mAbs were combined, without
changing the total amount of IgG added (1 mg/ml), dissocia-
tion scores greatly increased (Figure 5c). When NAK1, 2, 4, 7,
9, 10, and 11 mAbs were combined, the dissociation score
was equivalent to that of the AK23 mAb, hybridoma cells of
which can alone induce the PV phenotype in adult mice
(Tsunoda et al., 2003). When we removed some of NAK
mAbs from the combination, the dissociation scores gradually
decreased in general. The dissociation scores of the all
combinations were still higher than those of the individual
NAK mAbs, indicating a synergistic pathogenic effect
(representative data in Figure 5c). Considering these results
with those of the ascites formation assay, we speculate that
there may be a threshold of blister formation in vivo in adult
mice corresponding to a dissociation index of approximately
60% (dashed line in Figure 5c).
These findings indicate that individual NAK mAbs have
various pathogenic activities in disrupting the cell–cell
adhesion mediated by Dsg3, none individually potent
enough to induce an apparent PV phenotype in adult mice.
However, combinations of these mAbs show synergistic
effects above the threshold for blister formation and devel-
opment of the PV phenotype.
DISCUSSION
In this study, we generated 10 anti-Dsg3 IgG mAbs from PV
model mice produced by adoptive transfer of naive Dsg3/
splenocytes. All mAbs specifically reacted with native mouse
Dsg3, but not with mouse Dsg1. Some (NAK1, 3, 4, 7, 8, 9)
cross-reacted with human Dsgs, although the isoform
specificities of the mAbs were not necessarily conserved
between mouse and human. NAK1, NAK3, and NAK9
reacted only with human Dsg3, while NAK4 reacted with
both human Dsg3 and Dsg1, and NAK7 and NAK8 reacted
only with human Dsg1. These findings indicate that
antibodies against Dsgs have fine specificities, determined
by the few amino-acid residues that are not conserved
between mouse and human isoforms. This highlights the
difficulty of performing detailed evaluations of these
mouse antibodies using human skin or keratinocytes and
vice versa.
We performed three different assays to evaluate the
pathogenic activities of NAK mAbs: passive transfer, ascites
formation, and in vitro dissociation. The passive transfer
assay, by injection of IgG into neonatal mice, is well
established (Anhalt et al., 1982), and the ascites formation
assay, after inoculation of hybridoma cells into immunodefi-
cient adult mice, has been developed to evaluate in vivo
pathogenic activity of anti-Dsg3 mAbs (Tsunoda et al., 2003).
The passive transfer assay is more easily controlled than the
ascites formation assay. Highly concentrated IgG can be
applied to neonatal mice by passive transfer, while the
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Figure 5. In vitro keratinocyte dissociation assays demonstrated synergistic
pathogenic effects of NAK mAbs in the loss of keratinocyte cell–cell
adhesion. Sheets of mouse keratinocytes were treated with exfoliative toxin A
to digest Dsg1and with NAK mAbs, and subjected to mechanical stress. Cell
fragments were counted by image analysis. Representative data are shown.
(a) Dose dependency of NAK mAbs on dissociation scores. (b) NAK11
induced fragmentation while NAK3 did not. The combined mAbs generated
similar numbers of cell fragments as did AK23, an anti-Dsg3 mAb that is
able to induce the PV phenotype (Tsunoda et al., 2003). (c) Dissociation
indexes of NAK mAbs alone and in combination. The dissociation index
varied among the mAbs. Combinations of mAbs (adjusted to 1 mg/ml) had
higher dissociation indexes than individual NAK mAbs. Combining these
data with the results from ascites formation assays indicates that the threshold
for blister formation in vivo may be at a dissociation index of approximately
60% (dashed line).
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amount of IgG in an ascites formation assay is dependent on
the production rate of the hybridoma cells. Although these
two assays reflect in vivo pathogenic activity of anti-Dsg3 IgG
and subjective scaling can be used to represent the extent of
the phenotypic results (Mahoney et al., 1999; Aoki-Ota et al.,
2004), these assays do not measure pathogenic strength in a
quantitative manner. To compare pathogenic strengths
among pemphigus sera or anti-Dsg3 IgG mAbs, an in vitro
dissociation assay was developed using primary cultures of
human keratinocytes (Ishii et al., 2005). In this study, we
modified that assay using mouse keratinocytes to analyze the
potential of each NAK mAb.
Under passive transfer, eight of 10 mAbs showed
pathogenic activity and induced blister formation (Figure 3,
Tables 1 and 2), while only two of eight AK mAbs, isolated
from PV model mice receiving immunized Dsg3/ spleno-
cytes, were pathogenic (Tsunoda et al., 2003). The higher
frequency of pathogenicity among NAK mAbs is consistent
with the fact that although mice receiving naive Dsg3/
splenocytes showed lower titers of anti-Dsg3 IgG than did
those receiving immunized splenocytes, the two types of
mice showed no apparent differences in disease severity
(Aoki-Ota et al., 2004). The eight pathogenic NAK mAbs
recognized Ca2þ -dependent epitopes on Dsg3, while the
epitopes of the two nonpathogenic NAK mAbs were not
dependent on Ca2þ (Table 1). Similar results have been
seen with the AK mAbs: the two pathogenic antibodies
were dependent on Ca2þ , while the six nonpathogenic
AK mAbs were independent of Ca2þ (Tsunoda et al., 2003).
Most of pemphigus patients’ IgG autoantibodies recognize
Ca2þ -dependent epitopes on Dsg3 (Matis et al., 1987; Eyre
and Stanley, 1988; Amagai et al., 1995). These findings
together strongly suggest that pathogenic antibodies recog-
nize Ca2þ -dependent conformational epitopes while non-
pathogenic antibodies react with Ca2þ -independent linear
epitopes.
Although eight of 10 NAK mAbs showed pathogenic
activity in the passive transfer assay, none induced the PV
phenotype in the ascites formation assay (Figure 4, Table 1),
indicating that none were as potent as mAb AK23, which
could induce the PV phenotype in adult mice upon
hybridoma inoculation (Tsunoda et al., 2003). More sensitive
in vitro dissociation assays confirmed this and allowed us to
rank the pathogenicity of NAK mAbs (Figure 5). In fine
mapping using human Dsg1/Dsg3 point-mutated molecules,
the epitopes of NAK 1 and 9, which crossreacted with human
Dsg3, were mapped, respectively, to the amino-terminal T25,
Y28, and Q29 and to T25, Y28, Q29, V53-N56 of Dsg3.
These residues form a part of the adhesive interface of Dsg3
as predicted by crystal structure (Boggon et al., 2002), but are
different from the AK23 epitope (V3, K7, P8, and D59)
(Tsunoda et al., 2003). These findings suggest that the
residues V3, K7, P8, and D59 may form the critically
important part of the adhesive interface of Dsg3.
Although our attempt to isolate pathogenic anti-Dsg3
mAbs as potent as AK23 was not successful, pemphigus
patients’ sera always contain polyclonal anti-Dsg3 IgG
autoantibodies, which recognize different parts of the
molecule (Amagai et al., 1992; Sekiguchi et al., 2001). We
therefore tested the possibility that a combination of several
weakly pathogenic mAbs might show a synergistic effect and
induce the PV phenotype in adult mice. Indeed, when the
combination of hybridoma cells producing NAK1, 2, 4, and
7–11 were inoculated into Rag2/ mice, the recipients
developed the PV phenotype, with weight loss, patchy hair
loss, and crusted erosions around the snout (Table 3). The
minimal combination tested that was sufficient to induce the
phenotype in all mice tested was NAK1, 2, 7, and 11 mAbs or
NAK2, 3, 5, 11 mAbs (Figure 4). In vitro dissociation assays
confirmed the synergistic pathogenic effects of NAK mAbs
(Figure 5). This is the first demonstration of synergism among
antidesmoglein IgG antibodies in inducing the loss of
cell–cell adhesion of keratinocytes in vivo and in vitro.
In a previous study, AK mAbs recognizing the middle to
C-terminal extracellular domain of Dsg3 did not show
apparent pathogenic activity, suggesting that IgGs reacting
with functionally less important parts of the molecule do not
contribute to pathogenesis (Tsunoda et al., 2003). However,
in this study, NAK mAbs recognizing such regions showed
synergistic effects with mAbs reacting with the N-terminal
domain (e.g., mAbs NAK2, 3, and 9 or NAK2 and 11 in Figure
5c, Table 3). These findings provide molecular evidence that
anti-desmoglein IgG antibodies recognizing the middle to
C-terminal extracellular domains of Dsg3 can also take part
in the pathogenic process of blister formation.
We knew that the dose of antibodies is an important factor
to determine the pathogenic strength of patients’ sera because
antibody titers are generally correlated with the disease
activities when monitored in individual patients (Sams and
Jordon, 1971; Ishii et al., 1997; Cheng et al., 2002). We also
knew that the epitope of antibodies is another important
factor to determine the pathogenic strength of each anti-Dsg3
IgG (Tsunoda et al., 2003). In this study, we demonstrated
that the combination of different anti-Dsg3 IgG autoanti-
bodies is the third important factor because most, if not all,
patients’ sera contain polyclonal anti-Dsg3 IgG. Thus, the
clinical severity of the disease in each patient may be
determined in a more complex manner than initially
thought.
The preclinical condition in patients that precedes
development of PV remains to be elucidated. One possibility
is that one or a few nonpathogenic or weakly pathogenic
anti-desmoglein IgG autoantibody (or autoantibodies) are first
generated without inducing the apparent disease; additional
autoantibodies recognizing different epitopes on desmoglein
are subsequently produced, with the onset of the disease
phenotype. It would be interesting to study whether signal
transduction induced by the combined weakly pathogenic
NAK mAbs and by the single AK23 mAb are different. Also of
interest is whether long-term in vivo binding of weakly
pathogenic antibodies induces any secondary inflammation
in mice, including the recruitment of eosinophils. The weakly
pathogenic anti-Dsg3 NAK mAbs together with the potent
AK23 mAbs provide valuable tools to replicate and study the
polyclonal condition as found in patients, and to dissect the
molecular pathophysiology of pemphigus.
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MATERIALS AND METHODS
Mice
Dsg3/ offspring were obtained from matings of homozygotes
(Amagai et al., 2000b; Tsunoda et al., 2002). These mice had the
mixed genetic background of 129/SV (H-2b) and C57BL/6J (H-2b).
Splenocytes (5 107) were prepared from naive Dsg3/ mice, and
adoptively transferred into C57BL/6 Rag2/ mice (Central Institute
for Experimental Animals, Tokyo, Japan) via the tail vein, as
previously described (Aoki-Ota et al., 2004). Anti-Dsg3 antibody
production was examined by ELISA for recombinant mouse Dsg3,
and in vivo binding against Dsg3 was confirmed by live keratinocyte
staining (Tsunoda et al., 2002). All mouse studies were approved by
the Animal Ethics Review Board of Keio University.
Production of NAK mAbs
Splenocytes were isolated from mice that had the active PV
phenotype and fused with P3 mouse myeloma cells at a ratio of
5:1 with PEG 4000 (Merck, Darmstadt, Germany), followed by
selection with hypoxanthine–aminopterin–thymidine in the presence
of 10% hybridoma cloning factor (IGEN, Gaithersburg, MD).
Hybridoma cells were screened by ELISA using recombinant mouse
Dsg3 and positive clones were further examined by live keratinocyte
staining. Ten positive clones were screened and designated as NAK
(AK mAb from PV model mice by naive splenocyte transfer)
(Table 1). Each clone was obtained by three replicates of the
limiting dilution method. The isotypes of mAbs produced were
determined using an isotyping kit (Roche Diagnostics, Mannheim,
Germany). Antibodies were purified from culture supernatants
using the HiTrap rProtein A FF column (Amersham Biosciences,
Buckinghamshire, UK).
ELISA and live keratinocyte staining
The reactivities of antibodies with mouse Dsg3, mouse Dsg1, human
Dsg3, and human Dsg1 were measured by ELISA using the
respective recombinant Dsg molecules, as described previously
(Amagai et al., 2000b; Tsunoda et al., 2003; Anzai et al., 2004). In
brief, each sample was diluted 50,000-fold and run in duplicate. A
standard serum obtained from a Dsg3/ mouse immunized with
mDsg3/ was used as a positive control, and serum from a
nonimmunized mouse was used as a negative control. The ELISA
scores were calculated as index values using the formula: index
value¼ (OD450 of sampleOD450 of negative control)/(OD450 of
positive controlOD450 of negative control) 100. Live keratino-
cyte staining was performed using the mouse keratinocyte cell line
PAM212, as described previously (Amagai et al., 2000b; Tsunoda
et al., 2003). To confirm calcium sensitivity of epitopes, an EDTA-
treated ELISA was performed, incubating the ELISA plate with 5mM
EDTA prior to the assay.
Epitope mapping by immunoprecipitation using chimeric
desmogleins
Immunoprecipitation was performed using domain-swapped or
point-mutated Dsg1/Dsg3 molecules to determine mAb epitopes
(Tsunoda et al., 2003; Anzai et al., 2004). Typically, 3mg of purified
mAb and 200 ml of culture supernatant containing recombinant
protein were mixed and incubated at room temperature for
30 minutes. These proteins were immunoprecipitated with protein
G-Sepharose (Amersham Biosciences) overnight at 41C. Anti-E-tag
mAb (Amersham Biosciences) was used as a positive control. The
immunoprecipitates were fractionated by SDS-PAGE and blotted
onto a polyvinylidene difluoride membrane (Millipore, Bedford,
MA). The recombinant proteins were visualized with an anti-6x
histidine Ab (R&D Systems, Minneapolis, MN).
Passive transfer assays using neonatal mice
The pathogenic activities of the mAbs were evaluated by passive
transfer in neonatal mice, an established assay for the pathogenic
activity of pemphigus sera (Anhalt et al., 1982; Amagai et al., 1994).
We injected NAK mAbs (120–250mg/mouse, the highest dose we
injected per mice) either alone or together with a small amount of
total IgG prepared by ammonium sulfate precipitation of PF serum.
The dosage of PF IgG was set at 50% of that needed to induce gross
blistering, that is, 1 mg/mouse. Neonatal ICR (Institute of Cancer
Research) mice (Sankyo Lab Service, Tokyo, Japan) were used at
12–24 hours after birth (body weight 1.5–2.0 g). The skin was
evaluated grossly and microscopically 18–24 hours after injection.
To evaluate microscopic blisters, the entire body skin was sectioned
into six strips of about 3 mm in width. Blister formation was
considered positive when the length of a single lesion was greater
than 120mm or when more than two acantholytic lesions were found
after examining all six sections. Blisters found at the edges of sections
were not counted. To quantify the extent of blister formation
histologically, we calculated scores using the following formula:
histologic blister score¼ ((combined total length of all blistered
regions)/(combined total length of all sections examined)) 100.
Ascites formation assay
To evaluate the pathogenic activity of the NAK mAbs in adult mice,
we inoculated 5 106–1 107 cells, from individual hybridomas or
from a mixture of clones, into the peritoneum of Rag2/ mice
primed with 2,6,10,14-tetramethyl-pentadecane (Wako Pure Che-
mical Industries, Osaka, Japan). The inoculated mice were mon-
itored for ascites formation as well as for the appearance of the PV
phenotype, manifested by weight loss and patchy hair loss. Biopsies
of the oral mucous membranes and skin were taken when mice
developed the PV phenotype or when ascites formation was
observed after day 14.
In vitro dissociation assay
To evaluate the activity of mAbs in the inhibition of keratinocyte
cell–cell adhesion, we modified a previously described in vitro
dissociation assay (Ishii et al., 2005). For this study, we used primary
cultures of mouse keratinocytes rather than human keratinocytes. For
these cultures, skin specimens prepared from neonatal ICR mice at
12–24 hours of age were incubated in dispase II (Roche Diagnostics
Corp., Mannheim, Germany), and separated epidermis samples were
further incubated in 0.25% Trypsin (Invitrogen, Carlsbad, CA).
Isolated keratinocytes were dispensed into 12-well culture plates
with keratinocyte culture medium CnT-02 (CellnTec, St Gallen,
Switzerland). When keratinocytes were confluent, 1.2 mM calcium
was added and cells were incubated for 24 hours. Recombinant
exfoliative toxin A (0.25mg/ml) produced in E. coli, which specifically
digests mouse Dsg1 (Amagai et al., 2000a; Amagai et al., 2002), was
added to cultures 2 hours before the assay, in which 1mg/ml of
individual or pooled NAK mAbs (1mg/ml total) were added to culture
media. After washing with 0.9 mM Ca2þ -phosphate-buffered saline
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twice, mouse keratinocytes were incubated with dispase II for
15 minutes to release cells as sheets. Released sheets were carefully
washed twice with 0.9 mM Ca2þ -phosphate-buffered saline and
subjected to mechanical stress by pipetting with a 1 ml disposable
pipette tip. Fragments were fixed by adding formaldehyde to a final
concentration of 3% and were stained with crystal violet (Sigma-
Aldrich Co., St Louis, MO). A cell sheet treated with 1mg/ml of the
positive control mAb AK23 was included in each assay to adjust for
inter-assay variability. The mean number of particles was determined
by counting with Image Pro software (Media Cybernetics Inc., Silver
Spring, MD), using three sets of digital images captured for each plate.
Dissociation scores were calculated from the number of fragments (N)
as follows: Dissociation score¼ ((N with mAbN without mAb)/(N
with AK23N without mAb)) 100.
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